Abstract

Spent hens are egg-laying hens reaching the end of their egg-laying cycles, being a major byproduct of the egg industry. Recent studies have been focusing on finding new value-added uses for spent hens. We have previously identified four bioactive peptides from spent hen muscle proteins, including three angiotensin-converting enzyme (ACE) inhibitory (ACEi) peptides (VRP, LKY, and VRY), and one ACE2 upregulating (ACE2u) peptide (VVHPKESF (V-F)). In the current study, we further assessed their antioxidant and cytoprotective activities in two vascular cell lines—vascular smooth muscle A7r5 cells (VSMCs) and endothelial EA.hy926 cells (ECs)—upon stimulation by tumor necrosis factor alpha (TNFα) and angiotensin (Ang) II, respectively. The results from our study revealed that all four peptides attenuated oxidative stress in both cells. None of the investigated peptides altered the expression of TNFα receptors in ECs; however, VRY and V-F downregulated Ang II type 1 receptor (AT1R), while V-F upregulated the Mas receptor (MasR) in VSMCs. Further, we found that the antioxidant effects of VRP, LKY, and VRY were likely through acting as direct radical scavengers, while that of V-F was at least partially ascribed to increased endogenous antioxidant enzymes (GPx4 and SOD2) in both cells. Besides, as an ACE2u peptide, V-F exerted antioxidant effect in a MasR-dependent manner, indicating a possible involvement of the upregulated ACE2-MasR axis underlying its antioxidant action. The antioxidant activities of VRP, LKY, VRY, and V-F in vascular cells indicated their multifunctional properties, in addition to their ACEi or ACE2u activity, which supports their potential use as functional food ingredients against hypertension.

Highlights

  • Hypertension is the leading cause of global morbidity and mortality, afflicting more than 20% of adults [1,2]

  • The current study aims to explore the antioxidant effects of VRP, LKY, VRY, and V-F in vascular smooth muscle A7r5 cells (VSMCs) and EA.hy926 cells (ECs), as well as the underlying mechanisms underlying their antioxidant actions

  • VSMCs, we further studied the involvement of Ang II type 1 receptor (AT1 R) and Mas receptor (MasR) in the antioxidant actions

Read more

Summary

Introduction

Hypertension is the leading cause of global morbidity and mortality, afflicting more than 20% of adults [1,2]. Pharmaceutical drugs are the major treatment for hypertension, but prolonged use of pharmacological treatment is expensive and is generally associated with various adverse effects, such as dry cough and angioedema [3,4]. Food-derived bioactive compounds, such as antihypertensive peptides, have been an emerging treatment for the prevention and treatment of hypertension [5]. Despite the complicated pathogenesis of hypertension, the hyperactive renin–angiotensin system (RAS), endothelial dysfunction, and aberrant inflammation accompanied by excessive oxidative stress have been identified as important pathological contributors [6,7,8,9]. Redox stress and resultant oxidative damage are mediators of vascular impairment and inflammation in many cardiovascular diseases, including hypertension [10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call